Evaluation of ivabradine in left ventricular dyssynchrony and reverse remodeling in patients with chronic heart failure

Soylu K., ÇERİK İ. B., Aksan G., Nar G., Meric M.

JOURNAL OF ARRHYTHMIA, cilt.36, sa.4, ss.762-767, 2020 (ESCI) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 36 Sayı: 4
  • Basım Tarihi: 2020
  • Doi Numarası: 10.1002/joa3.12398
  • Dergi Adı: JOURNAL OF ARRHYTHMIA
  • Derginin Tarandığı İndeksler: Emerging Sources Citation Index (ESCI), Scopus, EMBASE, Directory of Open Access Journals
  • Sayfa Sayıları: ss.762-767
  • Anahtar Kelimeler: dyssynchrony, heart failure, ivabradine, CARDIAC-RESYNCHRONIZATION THERAPY, IDIOPATHIC DILATED CARDIOMYOPATHY, RATE REDUCTION, QRS DURATION, CARVEDILOL, DEFIBRILLATOR, ABNORMALITIES, MORTALITY, TRIAL
  • Sivas Cumhuriyet Üniversitesi Adresli: Evet

Özet

Objectives: Ivabradine is a pharmacological agent used in patients with heart failure and sinus rhythm. Its only known pharmacological effect is to slow the heart rate. In this study, we investigated the impact of ivabradine on dyssynchrony parameters in heart failure patients.